INDIAZydus Gets SEC Nod For Trials of Covid-19 AntibodyadminJune 4, 2021June 4, 2021 June 4, 2021June 4, 2021 Pharmaceuticals major Zydus Cadila has received permission from the Subject Expert Committee (SEC) to conduct clinical trials of its monoclonal antibodies (mAbs) based cocktail for...